The CAD $2.6 million pre-seed financing round included support from GlycoNet’s Kickstart Program.
Tag: therapeutics
2025 Wrapped at GlycoNet
A look back at this year’s highlights from the GlycoNet community, from growing partnerships to breakthroughs in glycomics—the study of complex sugar molecules.
2024 Wrapped at GlycoNet
Celebrating accomplishments and progress over the past year in glycomics—the science of complex sugars.
Researchers devise a quicker, more efficient way to make life-saving molecules
Improved method for creating nucleoside analogues opens the door to discovering countless treatments for everything from cancer to viral diseases.
Senator Paula Simons gets the sweet scoop on GlycoNet and glycomics
Senator Paula Simons recently toured GlycoNet at the University of Alberta, exploring the realm of glycomics. The visit highlighted GlycoNet’s pivotal role in advancing glycomics and its transformative impact across One Health domains, underlined by discussions with GlycoNet’s CEO, Dr. Elizabeth Nanak.
The tour of cutting-edge labs showcased passionate researchers driving innovation in glycomics, and interactions with start-ups like 48Hour Discovery shed light on drug discovery advancements. This visit emphasized the value of such engagements, illustrating the shared commitment to a thriving future and the potential for collaborative efforts to elevate healthcare and nurture a diverse bioeconomy.
Sweet science in the spotlight at the 2023 Canadian Glycomics Symposium
Over 150 top researchers, industry experts, and emerging talent in glycomics recently gathered in Edmonton, Alberta to discuss advancements and the latest trends in glycomics.
A Tour of the GlycoNet facilities with the Honourable Randy Boissonnault
A significant gathering of researchers, industry experts, and rising stars in glycomics recently took place in Edmonton, Alberta with the Honourable Randy Boissonnault, focusing on advancements and current trends in the field.
Top 10 stories from GlycoNet in 2022
A spotlight on some of the most exciting glycomics innovations from the past year.
Introducing a novel glycomics core service—48Hour Discovery
This accelerated service is designed to help academia and industry in molecular discovery in the areas of therapeutics, diagnostics, and probe development.